The price seemed to be holding up good around $2, until that conference call Oct 29. Sounds to me now like they might have to do a reverse split right out of the NASDAQ starting gate. I don't know if trust this CEO. He seems to be trying to pump up the stock at a time when the insiders have very little skin in the game.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links